Igenomix has agreed to sell the company to the Swedish fund EQT Partners. Its extensive experience in reproductive genetics, thanks to its collaboration with researchers, universities and high-tech companies, has led to this transaction, which is expected to close in May. Good Start Genetics and Genetaq are part of our global company sales research.
